These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

503 related items for PubMed ID: 23273966

  • 1. Cell mediated immune response after challenge in Omp25 liposome immunized mice contributes to protection against virulent Brucella abortus 544.
    Goel D, Rajendran V, Ghosh PC, Bhatnagar R.
    Vaccine; 2013 Feb 06; 31(8):1231-7. PubMed ID: 23273966
    [Abstract] [Full Text] [Related]

  • 2. Intradermal immunization with outer membrane protein 25 protects Balb/c mice from virulent B. abortus 544.
    Goel D, Bhatnagar R.
    Mol Immunol; 2012 Jun 06; 51(2):159-68. PubMed ID: 22464098
    [Abstract] [Full Text] [Related]

  • 3. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA, Estein SM, García Samartino C, Zwerdling A, Coria LM, Barrionuevo P, Fossati CA, Giambartolomei GH, Cassataro J.
    Infect Immun; 2009 Jan 06; 77(1):436-45. PubMed ID: 18981242
    [Abstract] [Full Text] [Related]

  • 4. Protective and therapeutic efficacy study of divalent fusion protein rL7/L12-Omp25 against B. abortus 544 in presence of IFNγ.
    Paul S, Peddayelachagiri BV, Nagaraj S, Konduru B, Batra HV.
    Appl Microbiol Biotechnol; 2018 Oct 06; 102(20):8895-8907. PubMed ID: 30136204
    [Abstract] [Full Text] [Related]

  • 5. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.
    Cassataro J, Estein SM, Pasquevich KA, Velikovsky CA, de la Barrera S, Bowden R, Fossati CA, Giambartolomei GH.
    Infect Immun; 2005 Dec 06; 73(12):8079-88. PubMed ID: 16299302
    [Abstract] [Full Text] [Related]

  • 6. Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus.
    Hop HT, Arayan LT, Huy TXN, Reyes AWB, Min W, Lee HJ, Park SJ, Chang HH, Kim S.
    Vaccine; 2018 May 17; 36(21):3027-3033. PubMed ID: 29678458
    [Abstract] [Full Text] [Related]

  • 7. Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection.
    Mallick AI, Singha H, Chaudhuri P, Nadeem A, Khan SA, Dar KA, Owais M.
    Vaccine; 2007 May 04; 25(18):3692-704. PubMed ID: 17296251
    [Abstract] [Full Text] [Related]

  • 8. Prediction of T cell epitopes of Brucella abortus and evaluation of their protective role in mice.
    Afley P, Dohre SK, Prasad GB, Kumar S.
    Appl Microbiol Biotechnol; 2015 Sep 04; 99(18):7625-37. PubMed ID: 26150246
    [Abstract] [Full Text] [Related]

  • 9. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A, Tibor A, Mertens P, De Bolle X, Michel P, Godefroid J, Walravens K, Letesson JJ.
    Infect Immun; 2001 Aug 04; 69(8):4816-22. PubMed ID: 11447155
    [Abstract] [Full Text] [Related]

  • 10. Recombinant L7/L12 protein entrapping PLGA (poly lactide-co-glycolide) micro particles protect BALB/c mice against the virulent B. abortus 544 infection.
    Singh D, Goel D, Bhatnagar R.
    Vaccine; 2015 Jun 04; 33(24):2786-92. PubMed ID: 25930114
    [Abstract] [Full Text] [Related]

  • 11. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
    Golshani M, Rafati S, Siadat SD, Nejati-Moheimani M, Shahcheraghi F, Arsang A, Bouzari S.
    Mol Immunol; 2015 Aug 04; 66(2):384-91. PubMed ID: 25968974
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of Brucella abortus DNA vaccine by expression of Cu-Zn superoxide dismutase antigen fused to IL-2.
    González-Smith A, Vemulapalli R, Andrews E, Oñate A.
    Immunobiology; 2006 Aug 04; 211(1-2):65-74. PubMed ID: 16446171
    [Abstract] [Full Text] [Related]

  • 13. An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB/c mice.
    Oñate AA, Donoso G, Moraga-Cid G, Folch H, Céspedes S, Andrews E.
    Infect Immun; 2005 Jun 04; 73(6):3294-300. PubMed ID: 15908354
    [Abstract] [Full Text] [Related]

  • 14. Recombinant outer membrane protein 25c from Brucella abortus induces Th1 and Th2 mediated protection against Brucella abortus infection in mouse model.
    Paul S, Peddayelachagiri BV, Nagaraj S, Kingston JJ, Batra HV.
    Mol Immunol; 2018 Jul 04; 99():9-18. PubMed ID: 29649688
    [Abstract] [Full Text] [Related]

  • 15. Non-infectious outer membrane vesicles derived from Brucella abortus S19Δper as an alternative acellular vaccine protects mice against virulent challenge.
    Solanki KS, Varshney R, Qureshi S, Thomas P, Singh R, Agrawal A, Chaudhuri P.
    Int Immunopharmacol; 2021 Jan 04; 90():107148. PubMed ID: 33189614
    [Abstract] [Full Text] [Related]

  • 16. A combined subunit vaccine comprising BP26, Omp25 and L7/L12 against brucellosis.
    Gupta S, Singh D, Gupta M, Bhatnagar R.
    Pathog Dis; 2019 Nov 01; 77(8):. PubMed ID: 31971564
    [Abstract] [Full Text] [Related]

  • 17. Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection.
    Ghasemi A, Jeddi-Tehrani M, Mautner J, Salari MH, Zarnani AH.
    Vaccine; 2014 Nov 20; 32(49):6659-66. PubMed ID: 25240754
    [Abstract] [Full Text] [Related]

  • 18. Co-immunization with interlukin-18 enhances the protective efficacy of liposomes encapsulated recombinant Cu-Zn superoxide dismutase protein against Brucella abortus.
    Singha H, Mallick AI, Jana C, Fatima N, Owais M, Chaudhuri P.
    Vaccine; 2011 Jun 24; 29(29-30):4720-7. PubMed ID: 21565241
    [Abstract] [Full Text] [Related]

  • 19. Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice.
    Delpino MV, Estein SM, Fossati CA, Baldi PC, Cassataro J.
    Vaccine; 2007 Sep 17; 25(37-38):6721-9. PubMed ID: 17686554
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of vaccination strategies against intranasal challenge with Brucella abortus in BALB/c mice.
    Surendran N, Sriranganathan N, Lawler H, Boyle SM, Hiltbold EM, Heid B, Zimmerman K, Witonsky SG.
    Vaccine; 2011 Mar 24; 29(15):2749-55. PubMed ID: 21316499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.